Itolizumab in addressing symptoms of acute respiratory distress syndrome (ARDS) with weaning off oxygen requirements in a COVID-19 patient: A case study
2021 ◽
Vol 6
(1)
◽
pp. 58-61
2011 ◽
Vol 2
(3)
◽
pp. 120
2011 ◽
Vol 2
(3)
◽
pp. 123
2009 ◽
Vol 102
(11)
◽
pp. 1150-1157
◽
2020 ◽
Vol 74
(4_Supplement_1)
◽
pp. 7411515368p1
2011 ◽
Vol 34
(2)
◽
pp. 165-174
◽